CSCI — COSCIENS Biopharma Share News
0.000.00%
Last trade - 00:00- CA$9.55m
- CA$4.91m
- $7.50m
Brief: Aeterna Zentaris Says Qtrly Loss Per Share $0.05
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:34 AM
Aeterna Zentaris: Plunges on $4.5 mln direct offering
Brief: Aeterna Zentaris Announces $4.5 Million Registered Direct Offering Priced At-The-Market
Brief: Aeterna Zentaris Says Final Results For Study P01 Expected In Q2
Brief: Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Requirement
Brief: Aeterna Zentaris Reports Qtrly Net Loss Per Share Of $0.02
Brief: Aeterna Zentaris Announces Appointment Of New President And CEO
Brief: Aeterna Zentaris Announces Pricing Of About $5 Mln Registered Direct Offering
Brief: Aeterna Zentaris Reports Qtrly Loss Per Share Of $0.01
Brief: Aeterna Zentaris Inc Files For Mixed Shelf Of Up To $45 Million
Brief: Aeterna Zentaris Reduces Size Of Its German Workforce
Brief: Aeterna Zentaris Qtrly Loss Per Common Share $0.30
Brief: Aeterna Zentaris Q4 Loss Per Share $0.31
Aeterna Zentaris: Rises on strategic review plans
NASDAQ RESUMED
Brief: Aeterna Zentaris Announces Strategic Review And Engagement Of Financial Advisor
NASDAQ TRADE HALT HALT NEWS PENDING
Brief: Aeterna Zentaris Receives European Marketing Clearance For Macimorelin